Physician

Alan Verm, MD

According to 2025 Medicare claims, Alan Verm, MD (NPI: 1558320382) practices ophthalmology in the Asheville, NC market, with the plurality of this provider's patient population coming from Henderson, NC. This provider's primary affiliated billing organization is LOOKING GLASS EYE CENTER PA (NPI: 1275592271; TIN: 020622351) and primary practice location at 28792-2808.

Verm's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,217 traditional Medicare patients, billed 10,736 HCPCS/CPT codes, and received $1,047,102 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 2,273 prescription claims across 588 beneficiaries totaling $209,749 in drug costs, led by Restasis (Cyclosporine). DME data shows 115 claims. Open Payments data shows 18 records totaling $386. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,806	5,054	$497,018
2016	1,753	4,925	$535,357
2017	1,727	4,947	$529,057
2018	1,825	5,177	$553,793
2019	1,985	5,376	$566,246
2020	1,809	4,620	$453,815
2021	1,928	5,015	$480,702
2022	2,291	6,034	$583,946
2023	2,076	5,332	$479,429
2024	2,217	10,736	$1,047,102

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	567	2,294	$213,854
2016	566	2,146	$221,774
2017	584	2,091	$218,786
2018	571	1,889	$207,214
2019	641	2,161	$239,582
2020	616	2,096	$242,363
2021	633	2,117	$208,087
2022	756	2,460	$237,573
2023	749	2,607	$218,780
2024	588	2,273	$209,749

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	287	312	$16,201
2016	289	335	$18,809
2017	271	289	$14,716
2018	178	190	$11,487
2019	151	170	$10,546
2020	133	133	$8,893
2021	100	105	$7,253
2022	123	124	$8,138
2023	96	96	$7,428
2024	115	115	$8,663

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92014	Established patient complete exam of visual system	1,543	1,663	$74
92012	Established patient problem focused exam of visual system	579	838	$56
92083	Exam of visual field with extended testing	369	393	$39
92134	Imaging of retina	581	973	$26
92133	Imaging of optic nerve	404	417	$24

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	34	2,220	$44,575
Lumigan	Bimatoprost	83	4,302	$35,822
Combigan	Brimonidine Tartrate/Timolol	34	2,126	$13,271
Latanoprost	Latanoprost	1,173	65,626	$12,428
Prednisolone Acetate	Prednisolone Acetate	155	4,305	$7,346

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2020	Frames, purchases	N	41	41	$2,879
V2303	Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, .12-2.00d cylinder, per lens	N	30	30	$2,729
V2300	Sphere, trifocal, plano to plus or minus 4.00d, per lens	N	19	19	$1,474
V2203	Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens	N	12	12	$898
V2103	Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens	N	13	13	$682

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$386	Tarsus Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alan Verm, MD?

Tedicare shows public-source Medicare data for Alan Verm, MD (NPI 1558320382), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alan Verm, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alan Verm, MD?

Alan Verm, MD is linked to LOOKING GLASS EYE CENTER PA (billing NPI 1275592271) in the available physician profile data.

Does Alan Verm, MD have Open Payments data?

Alan Verm, MD has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.